The sclerosing Sertoli cell tumor of the testis is an extremely rare entity.
Faaz Salah GomhaKamran Hassan BhattiAyad A YousifAyamn Mohammed SmainNadeem SohailKhalid Mohammed AbdelrahmanHuma ArshadAhmed H A ShaatWasim Sarwar BhattiNaeem Ahmed CheemaPublished in: Therapeutic advances in urology (2020)
We present the case of a 31-year-old single male patient, who was admitted through emergency unit with painless hard nodule of his left testis of 6 months' duration. Ultrasound scan of the scrotum showed a fairly well-defined hypo echoic area in the left testicular parenchyma in its middle part, measuring approximately 10 × 9 mm in size. We performed left inguinal radical orchidectomy. Histopathology examination of the left testis revealed sclerosing Sertoli cell tumor (SSCT) of the testis. This is a very rare testicular tumor with very few published case reports. Systemic examination was performed to exclude systemic metastasis. SSCT is characterized by the presence and aggregates of tubules of Sertoli cells, separated by a sclerotic intercellular matrix formed by fibrotic connective tissue.
Keyphrases
- germ cell
- single cell
- case report
- cell therapy
- public health
- magnetic resonance imaging
- induced apoptosis
- computed tomography
- emergency department
- randomized controlled trial
- idiopathic pulmonary fibrosis
- systematic review
- systemic sclerosis
- signaling pathway
- stem cells
- magnetic resonance
- cell proliferation
- mesenchymal stem cells
- drug induced
- bone marrow